Partial federal government shutdown
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
Coronary artery disease (CAD), also referred to as coronary heart disease (CHD) or ischemic heart disease (IHD), is a leading cause of death for both men and women in the United States and is the most common form of cardiovascular disease. Accurate and early assessment of patients with symptomatic CAD is important for risk management and initiation of appropriate treatments to reduce morbidity and mortality. Noninvasive anatomic tests provide information on location and extent of blockage and include coronary CT angiography (CCTA) and cardiac magnetic resonance imaging (CMRI).
Status: Decision completed
The Health Technology Assessment (HTA) program conducted assessments on Coronary Computed Tomographic Angiography (CCTA) and cardiac nuclear imaging in 2008 and 2013 respectively. The current assessment will reevaluate imaging for diagnosis of CAD based on newer evidence on CCTA and stress cardiac nuclear imaging.
Type | Materials |
---|---|
Assessment (2021) | |
Related topics |